Zhangzhou Pientzehuang Pharmaceutical Stock Beneish M Score

600436 Stock   206.02  1.41  0.69%   
This module uses fundamental data of Zhangzhou Pientzehuang to approximate the value of its Beneish M Score. Zhangzhou Pientzehuang M Score tells investors if the company management is likely to be manipulating earnings. The score is calculated using eight financial indicators that are adjusted by a specific multiplier. Please note, the M Score is a probabilistic model and cannot detect companies that manipulate their earnings with 100% accuracy. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Zhangzhou Pientzehuang Pharmaceutical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
  
As of March 24, 2025, Long Term Debt is expected to decline to about 38.7 M. In addition to that, Short and Long Term Debt is expected to decline to about 765.8 M.
At this time, Zhangzhou Pientzehuang's M Score is inapplicable. The earnings manipulation may begin if Zhangzhou Pientzehuang's top management creates an artificial sense of financial success, forcing the stock price to be traded at a high price-earnings multiple than it should be. In general, excessive earnings management by Zhangzhou Pientzehuang executives may lead to removing some of the operating profits from subsequent periods to inflate earnings in the following periods. This way, the manipulation of Zhangzhou Pientzehuang's earnings can lead to misrepresentations of actual financial condition, taking the otherwise loyal stakeholders on to the path of questionable ethical practices and plain fraud.
-2.81
Beneish M Score - Inapplicable
Elasticity of Receivables

1.0

Focus
Asset Quality

0.95

Focus
Expense Coverage

1.0

Focus
Gross Margin Strengs

N/A

Focus
Accruals Factor

1.0

Focus
Depreciation Resistance

N/A

Focus
Net Sales Growth

1.05

Focus
Financial Leverage Condition

1.0

Focus

Zhangzhou Pientzehuang Beneish M-Score Indicator Trends

The cure to earnings manipulation is the transparency of financial reporting. It will typically remove the temptation of the top executives to inflate earnings (i.e., to promote the idea of 'winning at any cost'). Because a healthy internal audit department can enhance transparency, the board should promote the auditors' access to all the record-keeping systems across the enterprise. For example, if Zhangzhou Pientzehuang's auditors report directly to the board (not management), the managers will be reluctant to manipulate simply due to the fear of punishment. On the other hand, the auditors will be free to investigate the ledgers properly because they know that the board has their back.
Current ValueLast YearChange From Last Year 10 Year Trend
Net Receivables1.1 BB
Sufficiently Up
Slightly volatile
Total Revenue12.1 B11.6 B
Sufficiently Up
Slightly volatile
Total Assets20.6 B19.6 B
Sufficiently Up
Slightly volatile
Total Current Assets18.2 B17.4 B
Sufficiently Up
Slightly volatile
Non Current Assets Total1.9 B2.3 B
Significantly Down
Slightly volatile
Property Plant Equipment562.2 M535.5 M
Sufficiently Up
Slightly volatile
Selling General Administrative846.2 M805.9 M
Sufficiently Up
Slightly volatile
Total Current Liabilities3.5 B3.3 B
Sufficiently Up
Slightly volatile
Non Current Liabilities Total209 M318.3 M
Way Down
Slightly volatile
Short Term Debt519.7 M689.5 M
Way Down
Slightly volatile
Long Term Debt38.7 M40.8 M
Notably Down
Slightly volatile
Operating Income3.9 B3.8 B
Sufficiently Up
Slightly volatile
Short Term Investments9.6 M7.9 M
Fairly Up
Slightly volatile
Long Term Investments895.5 MB
Fairly Down
Slightly volatile

Zhangzhou Pientzehuang Beneish M-Score Driver Matrix

One of the toughest challenges investors face today is learning how to quickly synthesize historical financial statements and information provided by the company, SEC reporting, and various external parties in order to detect the potential manipulation of earnings. Understanding the correlation between Zhangzhou Pientzehuang's different financial indicators related to revenue, expenses, operating profit, and net earnings helps investors identify and prioritize their investing strategies towards Zhangzhou Pientzehuang in a much-optimized way. Analyzing correlations between earnings drivers directly associated with dollar figures is the most effective way to find Zhangzhou Pientzehuang's degree of accounting gimmicks and manipulations.

About Zhangzhou Pientzehuang Beneish M Score

M-Score is one of many grading techniques for value stocks. It was developed by Professor M. Daniel Beneish of the Kelley School of Business at Indiana University and published in 1999 under the paper titled The Detection of Earnings Manipulation. The Beneish score is a multi-factor model that utilizes financial identifiers to compile eight variables used to classify whether a company has manipulated its reported earnings. The variables are built from the officially filed financial statements to create a final score call 'M Score.' The score helps to identify companies that are likely to manipulate their profits if they show deteriorating gross margins, operating expenses, and leverage against growing revenue.

Reconciled Depreciation

92.4 Million

At present, Zhangzhou Pientzehuang's Reconciled Depreciation is projected to increase significantly based on the last few years of reporting.

Zhangzhou Pientzehuang Earnings Manipulation Drivers

Although earnings manipulation is typically not the result of intentional misconduct by the c-level executives, it is still a widespread practice by the senior management of public companies such as Zhangzhou Pientzehuang. It is usually done by a series of misrepresentations of various accounting rules and operating activities across multiple financial cycles. The best way to spot the manipulation is to examine the historical financial statement to find inconsistencies in earning reports to find trends in assets or liabilities that are not sustainable in the future.
202020212022202320242025 (projected)
Net Receivables509.5M612.3M744.4M911.7M1.0B1.1B
Total Revenue6.5B8.0B8.7B10.1B11.6B12.1B
Total Assets10.2B12.5B14.6B17.1B19.6B20.6B
Total Current Assets8.3B10.6B12.7B15.1B17.4B18.2B
Operating Income1.8B2.8B2.9B3.3B3.8B3.9B
Investments15.0M143.3M(6.2B)(2.1B)(1.9B)(1.8B)

About Zhangzhou Pientzehuang Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Zhangzhou Pientzehuang Pharmaceutical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Zhangzhou Pientzehuang using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Zhangzhou Pientzehuang Pharmaceutical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in Zhangzhou Stock

Zhangzhou Pientzehuang financial ratios help investors to determine whether Zhangzhou Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Zhangzhou with respect to the benefits of owning Zhangzhou Pientzehuang security.